Sat.Jan 15, 2022 - Fri.Jan 21, 2022

article thumbnail

Billionaire-backed “rejuvenation” start-up Altos Labs launches operations

pharmaphorum

Just months after the venture was unveiled, controversial biotechnology company Altos Labs has officially launched with $3 billion in funding secured from investors. Dubbed an ‘anti-ageing’ company, Altos has gained mainstream attention for its focus on ‘rejuvenation’ and biological reprogramming technology. While the specific research goals have been kept a closely guarded secret, some scientists propose that rejuvenating cells in a lab could be a path to prolonging huma

130
130
article thumbnail

Global digital health funding skyrockets to $57.2B with record cash for mental health, telehealth

Fierce Healthcare

Global digital health funding skyrockets to $57.2B with record cash for mental health, telehealth. hlandi. Fri, 01/21/2022 - 11:17.

143
143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Which PCD Products Are The Best To Start A Pharma Franchise?

Fossil Remedies

We know that the PCD Pharma Franchise business is lucrative and profitable. But do we know which PCD products should we pick so that the maximum profitability is ensured? Perhaps no. This blog is an attempt to clarify the concepts about choosing the best products. First, choose the right company. Experts say that one should choose an ISO-certified company that works as per the standards and guidelines laid by WHO and GMP.

98
article thumbnail

ililli: How Social Audio is Driving HCP Engagement

Pharma Marketing Network

Talk to me. Pharma brands that want deep engagements need to look at and listen to social audio. It’s not surprising. In fact, it’s the most direct route to your goal. You want to talk to doctors? To start the conversation, we put pictures in front of them, bombarded them with videos, retarget them, and then send them emails. We want to talk, and they want to listen.

97
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Novo Nordisk moves to strengthen obesity efforts

pharmaphorum

After securing FDA approval for Wegovy last year, Novo Nordisk is strengthening its position in the obesity space through a collaboration with EraCal Therapeutics. Under the joint research plan, the Danish giant will work with EraCal to identify novel drug targets relevant for food intake regulation and additional metabolic phenotypes. Although specific details of the collaboration are yet to be released, EraCal has confirmed that the duo will utilise its phenotypic drug discovery platform to id

FDA 123
article thumbnail

Fierce JPM Week: Women are the 'power buyers' of healthcare. Here's how to serve them better

Fierce Healthcare

Fierce JPM Week: Women are the 'power buyers' of healthcare. Here's how to serve them better. hlandi. Wed, 01/19/2022 - 13:54.

142
142

More Trending

article thumbnail

Botanical Solution Inc. (BSI) Secures $6.1 Million in Series A First Closing

Pharma Mirror

January 17, 2022 (Davis, CA) – Botanical Solution Inc. (BSI), innovator of sustainable, consistent, and cost-effective Advanced Botanical Materials for agricultural and pharmaceutical applications, has successfully closed $6.1 million in a Series A round led by Palo Alto based VC Firm, Otter Capital. This round of funding will enhance BSI’s value proposition by facilitating the geographic expansion of its current botanical-based products and the development of a new product pipeline derive

59
article thumbnail

CVS Health and Microsoft alliance: an example of an extended partnership

pharmaphorum

Microsoft and CVS Health have announced a new strategic alliance focusing on personalised care and accelerating digital transformation for the benefit of CVS customers and its employees. David Rhew, MD, global chief medical officer and VP of healthcare at Microsoft, tells us, “Using Microsoft technology, CVS Health will develop a more agile, digital-first technology foundation.” Digital innovation and implementation have skyrocketed within healthcare due to the need to adapt quickly

article thumbnail

Cigna study: Virtual care can reduce unnecessary ER, urgent care visits by 19%

Fierce Healthcare

Cigna study: Virtual care can reduce unnecessary ER, urgent care visits by 19%. pminemyer. Fri, 01/21/2022 - 14:24.

145
145
article thumbnail

Will new Facebook ad policy shake up clinical trial recruitment?

Outsourcing Pharma

An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment.

117
117
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Approval for Covishield by the UK Government

Druggist

There are many problems and disorders which can cause trouble in your sleep like. All are easy to deal with but difficult to cure. One problem that needs special attention among these is – SLEEP APNEA. With this article on sleep apnea, read on and stay glued till the end to know an eye-opener fact and health advice on how to use “Modafinil Drug for Sleep Apnea”- the right way and right choice of treatment.

52
article thumbnail

GSK rejects $68.4bn Unilever bid for consumer health

pharmaphorum

GlaxoSmithKline (GSK) claims it has rejected three unsolicited, conditional and non-binding proposals from Unilever to acquire GSK Consumer Healthcare in a deal worth approximately $68.4 billion (£50 billion). The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%.

119
119
article thumbnail

Microsoft, Cleveland Clinic and Providence join coalition to innovate AI in healthcare

Fierce Healthcare

Microsoft, Cleveland Clinic and Providence join coalition to innovate AI in healthcare. rtorrence. Tue, 01/18/2022 - 11:32.

137
137
article thumbnail

Pfizer: COVID-19 treatment shows promise against omicron variant

Outsourcing Pharma

The pharmaceutical company reports studies have demonstrated the main protease inhibitor of Paxlovid maintains in vitro efficiency against the variant.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022

Pharma Mirror

ADELAIDE, Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has secured a significant investment from global private equity firm, The Riverside Company (Riverside), to support further regional and global expansion. The investment values the company in excess of $200m. Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive 43.5% rebate,

52
article thumbnail

Two new drugs added to WHO list of COVID-19 therapies

pharmaphorum

A World Health Organization (WHO) panel has given the green light to two new drugs to treat COVID-19. US-based Eli Lilly’s baricitinib (Olumiant), a Janus kinase inhibitor, and GlaxoSmithKline and Vir Biotechnology’s sotrovimab, a monoclonal antibody, were recommended in new WHO guidelines, published in the British Medical Journal. . Baricitinib, administered with corticosteroids, was strongly recommended as a treatment for patients with severe or critical illness.

Hospitals 116
article thumbnail

Study: Insurers spend nearly $130M a year on ivermectin prescriptions

Fierce Healthcare

Study: Insurers spend nearly $130M a year on ivermectin prescriptions. pminemyer. Tue, 01/18/2022 - 16:23.

Insurance 145
article thumbnail

Vanderbilt discovery offers hope for colorectal cancer patients

Outsourcing Pharma

The researchers, in studying how polyps morph into colorectal cancer, have set a path for improved surveillance of the disease, harnessing precision medicine.

108
108
article thumbnail

Almirall and IRB Barcelona announce a research collaboration to discover novel molecular glue therapeutics for severe skin diseases

Pharma Mirror

BARCELONA, Spain, a global biopharmaceutical company focused on skin health, and IRB Barcelona (the Institute for Research in Biomedicine), an independent, international research centre engaged in fundamental and applied biomedical science, announced today a research collaboration to identify new oral treatments for immune-inflammatory skin diseases with remaining high unmet medical needs using molecular glue degraders, a novel therapeutic modality.

article thumbnail

Covid vaccine booster raises antibody levels in fight against Omicron

pharmaphorum

A third dose of vaccine has been shown to effectively neutralise the Omicron variant of covid-19, according to researchers. Research led by UCLH, UCL and the Francis Crick Institute found that the booster dose successfully stimulates antibody levels that neutralise Omicron. Details of the study were published in The Lancet this week. UCLH researchers stated that antibodies generated in people who had received only two doses of either the Oxford/AstraZeneca vaccine or the Pfizer/BioNTech vaccin

Vaccines 115
article thumbnail

IBM sells Watson Health assets to investment firm Francisco Partners

Fierce Healthcare

IBM sells Watson Health assets to investment firm Francisco Partners. hlandi. Fri, 01/21/2022 - 09:44.

144
144
article thumbnail

UK agency opens future of clinical trials to the public

Outsourcing Pharma

The Medicines and Healthcare Products Regulatory Agency has released proposals to bolster trials legislation, asking citizens for input on the suggestions.

98
article thumbnail

Learn How to Lose Weight with These Surprising Tips

Tria Health Blog

Losing weight can sometimes feel like the easy part in your weight loss journey. The hard part is keeping that weight off and being consistent in your weight loss goals.

52
article thumbnail

Gilead takes legal action against counterfeit HIV drug network 

pharmaphorum

US pharma giant Gilead Sciences has accused a network of unauthorised suppliers and distributors of selling more than $250 million of counterfeit versions of its HIV medications. According to the company, the defendants reportedly sold 85,247 bottles of medicine with counterfeit Gilead labelling to pharmacies over a two-year period, using falsified supply chain documentation to conceal their origin.

article thumbnail

Cyberattacks top list of 2022 health tech hazards alongside supply chain problems, damaged infusion pumps

Fierce Healthcare

Cyberattacks top list of 2022 health tech hazards alongside supply chain problems, damaged infusion pumps. rtorrence. Thu, 01/20/2022 - 15:20.

122
122
article thumbnail

AML digital therapeutic lands Breakthrough Device Designation from FDA

Outsourcing Pharma

Blue Note Therapeutics has announced the status has been granted to BNT200, a device to treat anxiety and depression in acute myeloid leukemia patients.

FDA 96
article thumbnail

Scandi pharma: Swede deal for Psyros Diagnostics

Pharma Times

Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC) technology enables the measurement of disease-indicating molecules in extremely low concentrations–in ten minutes or less.

49
article thumbnail

Decentralised trials: beyond the pandemic

pharmaphorum

The adoption of decentralised activities was a major factor in allowing clinical trials to continue during the early stages of the pandemic. Ben Hargreaves examines whether this adoption looks set to become a permanent feature of clinical trials moving into the future, rather than just supplying the tools to a temporary need. Decentralised clinical trials (DCTs) have become a major talking point due to their ability to ensure that drug development can continue efficiently through the current pan

105
105
article thumbnail

Biden confident he can get 'big chunks' of $1.75T Build Back Better Act signed into law

Fierce Healthcare

Biden confident he can get 'big chunks' of $1.75T Build Back Better Act signed into law. rking. Wed, 01/19/2022 - 17:12.

130
130
article thumbnail

Tech Innovations: January 2022

Outsourcing Pharma

This monthâs list of new technology, partnerships, and other announcements includes items from ObvioHealth, Datavant, HumanFirst, and other industry players.

52
article thumbnail

Lasmiditan Versus Triptans

Med Ed 101

Lasmiditan (Reyvow) is an agent that can be utilized for acute migraine treatment. It works slightly differently than triptans. While triptans target serotonin receptor subtypes 1B and 1D, lasmiditan targets serotonin receptor subtype 1F. The biggest reason that this matters is that by having selective agonist activity at 1F, we can likely avoid some of […].

40
article thumbnail

Don’t be afraid to change

pharmaphorum

The digital revolution generated by the pandemic fractured lines of connection and severed the life-blood of being able to meet with clinicians for sales teams and MSLs. It created a fundamental shift in operating practice that has skewed product launches, sales and scientific communication but experts are advocating that companies embrace the change and use it to energise performance.

article thumbnail

Bullish on growing use of telehealth, Wheel banks $150M to expand white-labeled virtual care services

Fierce Healthcare

Bullish on growing use of telehealth, Wheel banks $150M to expand white-labeled virtual care services. hlandi. Wed, 01/19/2022 - 16:26.

Labelling 122
article thumbnail

Tech Innovations: December 2021

Outsourcing Pharma

This monthâs list of new technology, partnerships, and other announcements includes items from ObvioHealth, Datavant, HumanFirst, and other industry players.

52